NES
PCYC

New England Securities’s PHARMACYCLICS INC PCYC Stock Holding History

New England Securities’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1
Closed – – 1912
2014
Q1 		$0 Buy
+1
New +$130 ﹤0.01% 1890

Other funds holding PCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

New England Securities's PCYC Position: Q2 2014 in Review

New England Securities sold out of PHARMACYCLICS INC (PCYC) in Q2 2014, closing a stake of 1 share.

New England Securities first reported a position in PCYC in Q1 2014 and held it in 1 quarter. The position peaked at $0 in Q1 2014. 251 funds tracked by Wall St. Rank hold PCYC as of Q2 2014.

  • New England Securities reported no remaining PHARMACYCLICS INC position as of Q2 2014 after selling out during the quarter.
  • New England Securities sold 1 PHARMACYCLICS INC share in Q2 2014.
  • New England Securities first reported a position in PHARMACYCLICS INC in Q1 2014 and held it in 1 quarter.
  • New England Securities's PHARMACYCLICS INC position peaked at $0 in Q1 2014.
  • 251 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2014.

Based on New England Securities's 13F filing for Q2 2014, filed 4 Aug 2014.